Overview

The compagny is based on a novel platform technology for pathogen identification using enhanced electrochemical nucleic acid detection. The platform reduces the time required for identification from 2-3 days down to just two hours while vastly reducing the hands-on time required. In sepsis and many other cases such a technology will be hugely beneficial.